Generic Injectables Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Generic Injectables Market to 2027 - Global Analysis and Forecasts By Product (Monoclonal Antibodies, Cytokines, Insulin, Vaccines, Others); Indication (Diabetes, Cancer, Cardiovascular Disease, Infections, Others); End User (Hospital Pharmacy, Retail Pharmacy, Drug Stores, Online Prescription Stores)

Report Code: TIPRE00004765 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Generic Injectables are safe and effective innovator bio-equivalent drugs of their branded counterparts which are not protected by drug patents. They have similar ingredient, dosage, strength, quality, form, etc.

MARKET DYNAMICS
The Generic Injectables market is anticipated to grow in the forecast, owing to the factors such as growing efforts for manufacturing sterile generic injectable, rising number of prescriptions for generic injectable, shortage of branded sterile, and expansion by the key players. Nevertheless, complexity of manufacturing and stringency in the process and production of these are expected to restrict the growth of the market.

MARKET SCOPE
The "Global Generic Injectables Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of Generic Injectables market with detailed market segmentation by Product, Indication, End User and geography. The global Generic Injectables market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Generic Injectables market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Generic Injectables market is segmented on the basis of Product, Indication and End User. Based on Product the market is segmented into Monoclonal Antibodies, Cytokines, Insulin, Vaccines, Others. Based on Indication the market is segmented into Diabetes, Cancer, Cardiovascular Disease, Infections, Others. Based on End User the market is segmented into Hospital Pharmacy, Retail Pharmacy, Drug Stores, Online Prescription Stores.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Generic Injectables market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Generic Injectables market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Generic Injectables market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Generic Injectables market in these regions.

MARKET PLAYERS
The reports cover key developments in the Generic Injectables market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Generic Injectables market are anticipated to lucrative growth opportunities in the future with the rising demand for Generic Injectables market in the global market. Below mentioned is the list of few companies engaged in the Generic Injectables market.

The report also includes the profiles of Generic Injectables market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Pfizer, Inc
  • Novartis AG
  • Baxter
  • Teva Pharmaceutical Industries Ltd
  • Hikma Pharmaceuticals plc
  • Sanofi
  • Dr. Reddy's Laboratories
  • Aurobindo Pharma
  • GlaxoSmithKline plc
AstraZeneca plc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Generic Injectables Market - By Product
1.3.2 Generic Injectables Market - By Indication
1.3.3 Generic Injectables Market - By End User
1.3.4 Generic Injectables Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GENERIC INJECTABLES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GENERIC INJECTABLES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GENERIC INJECTABLES MARKET - GLOBAL MARKET ANALYSIS
6.1. GENERIC INJECTABLES - GLOBAL MARKET OVERVIEW
6.2. GENERIC INJECTABLES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. GENERIC INJECTABLES MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. MONOCLONAL ANTIBODIES
7.3.1. Overview
7.3.2. Monoclonal Antibodies Market Forecast and Analysis
7.4. CYTOKINES
7.4.1. Overview
7.4.2. Cytokines Market Forecast and Analysis
7.5. INSULIN
7.5.1. Overview
7.5.2. Insulin Market Forecast and Analysis
7.6. VACCINES
7.6.1. Overview
7.6.2. Vaccines Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. GENERIC INJECTABLES MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. DIABETES
8.3.1. Overview
8.3.2. Diabetes Market Forecast and Analysis
8.4. CANCER
8.4.1. Overview
8.4.2. Cancer Market Forecast and Analysis
8.5. CARDIOVASCULAR DISEASE
8.5.1. Overview
8.5.2. Cardiovascular Disease Market Forecast and Analysis
8.6. INFECTIONS
8.6.1. Overview
8.6.2. Infections Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. GENERIC INJECTABLES MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACY
9.3.1. Overview
9.3.2. Hospital Pharmacy Market Forecast and Analysis
9.4. RETAIL PHARMACY
9.4.1. Overview
9.4.2. Retail Pharmacy Market Forecast and Analysis
9.5. DRUG STORES
9.5.1. Overview
9.5.2. Drug Stores Market Forecast and Analysis
9.6. ONLINE PRESCRIPTION STORES
9.6.1. Overview
9.6.2. Online Prescription Stores Market Forecast and Analysis
10. GENERIC INJECTABLES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Generic Injectables Market Overview
10.1.2 North America Generic Injectables Market Forecasts and Analysis
10.1.3 North America Generic Injectables Market Forecasts and Analysis - By Product
10.1.4 North America Generic Injectables Market Forecasts and Analysis - By Indication
10.1.5 North America Generic Injectables Market Forecasts and Analysis - By End User
10.1.6 North America Generic Injectables Market Forecasts and Analysis - By Countries
10.1.6.1 United States Generic Injectables Market
10.1.6.1.1 United States Generic Injectables Market by Product
10.1.6.1.2 United States Generic Injectables Market by Indication
10.1.6.1.3 United States Generic Injectables Market by End User
10.1.6.2 Canada Generic Injectables Market
10.1.6.2.1 Canada Generic Injectables Market by Product
10.1.6.2.2 Canada Generic Injectables Market by Indication
10.1.6.2.3 Canada Generic Injectables Market by End User
10.1.6.3 Mexico Generic Injectables Market
10.1.6.3.1 Mexico Generic Injectables Market by Product
10.1.6.3.2 Mexico Generic Injectables Market by Indication
10.1.6.3.3 Mexico Generic Injectables Market by End User
10.1.6.4 US Generic Injectables Market
10.1.6.4.1 US Generic Injectables Market by Product
10.1.6.4.2 US Generic Injectables Market by Indication
10.1.6.4.3 US Generic Injectables Market by End User
10.2. EUROPE
10.2.1 Europe Generic Injectables Market Overview
10.2.2 Europe Generic Injectables Market Forecasts and Analysis
10.2.3 Europe Generic Injectables Market Forecasts and Analysis - By Product
10.2.4 Europe Generic Injectables Market Forecasts and Analysis - By Indication
10.2.5 Europe Generic Injectables Market Forecasts and Analysis - By End User
10.2.6 Europe Generic Injectables Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Generic Injectables Market
10.2.6.1.1 Germany Generic Injectables Market by Product
10.2.6.1.2 Germany Generic Injectables Market by Indication
10.2.6.1.3 Germany Generic Injectables Market by End User
10.2.6.2 France Generic Injectables Market
10.2.6.2.1 France Generic Injectables Market by Product
10.2.6.2.2 France Generic Injectables Market by Indication
10.2.6.2.3 France Generic Injectables Market by End User
10.2.6.3 Italy Generic Injectables Market
10.2.6.3.1 Italy Generic Injectables Market by Product
10.2.6.3.2 Italy Generic Injectables Market by Indication
10.2.6.3.3 Italy Generic Injectables Market by End User
10.2.6.4 Spain Generic Injectables Market
10.2.6.4.1 Spain Generic Injectables Market by Product
10.2.6.4.2 Spain Generic Injectables Market by Indication
10.2.6.4.3 Spain Generic Injectables Market by End User
10.2.6.5 United Kingdom Generic Injectables Market
10.2.6.5.1 United Kingdom Generic Injectables Market by Product
10.2.6.5.2 United Kingdom Generic Injectables Market by Indication
10.2.6.5.3 United Kingdom Generic Injectables Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Generic Injectables Market Overview
10.3.2 Asia-Pacific Generic Injectables Market Forecasts and Analysis
10.3.3 Asia-Pacific Generic Injectables Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Generic Injectables Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Generic Injectables Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Generic Injectables Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Generic Injectables Market
10.3.6.1.1 Australia Generic Injectables Market by Product
10.3.6.1.2 Australia Generic Injectables Market by Indication
10.3.6.1.3 Australia Generic Injectables Market by End User
10.3.6.2 China Generic Injectables Market
10.3.6.2.1 China Generic Injectables Market by Product
10.3.6.2.2 China Generic Injectables Market by Indication
10.3.6.2.3 China Generic Injectables Market by End User
10.3.6.3 India Generic Injectables Market
10.3.6.3.1 India Generic Injectables Market by Product
10.3.6.3.2 India Generic Injectables Market by Indication
10.3.6.3.3 India Generic Injectables Market by End User
10.3.6.4 Japan Generic Injectables Market
10.3.6.4.1 Japan Generic Injectables Market by Product
10.3.6.4.2 Japan Generic Injectables Market by Indication
10.3.6.4.3 Japan Generic Injectables Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Generic Injectables Market Overview
10.4.2 Middle East and Africa Generic Injectables Market Forecasts and Analysis
10.4.3 Middle East and Africa Generic Injectables Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Generic Injectables Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Generic Injectables Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Generic Injectables Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Generic Injectables Market
10.4.6.1.1 South Africa Generic Injectables Market by Product
10.4.6.1.2 South Africa Generic Injectables Market by Indication
10.4.6.1.3 South Africa Generic Injectables Market by End User
10.4.6.2 Saudi Arabia Generic Injectables Market
10.4.6.2.1 Saudi Arabia Generic Injectables Market by Product
10.4.6.2.2 Saudi Arabia Generic Injectables Market by Indication
10.4.6.2.3 Saudi Arabia Generic Injectables Market by End User
10.4.6.3 U.A.E Generic Injectables Market
10.4.6.3.1 U.A.E Generic Injectables Market by Product
10.4.6.3.2 U.A.E Generic Injectables Market by Indication
10.4.6.3.3 U.A.E Generic Injectables Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Generic Injectables Market Overview
10.5.2 South and Central America Generic Injectables Market Forecasts and Analysis
10.5.3 South and Central America Generic Injectables Market Forecasts and Analysis - By Product
10.5.4 South and Central America Generic Injectables Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Generic Injectables Market Forecasts and Analysis - By End User
10.5.6 South and Central America Generic Injectables Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Generic Injectables Market
10.5.6.1.1 Brazil Generic Injectables Market by Product
10.5.6.1.2 Brazil Generic Injectables Market by Indication
10.5.6.1.3 Brazil Generic Injectables Market by End User
10.5.6.2 Argentina Generic Injectables Market
10.5.6.2.1 Argentina Generic Injectables Market by Product
10.5.6.2.2 Argentina Generic Injectables Market by Indication
10.5.6.2.3 Argentina Generic Injectables Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. GENERIC INJECTABLES MARKET, KEY COMPANY PROFILES
12.1. PFIZER, INC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BAXTER
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. TEVA PHARMACEUTICAL INDUSTRIES LTD
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. HIKMA PHARMACEUTICALS PLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SANOFI
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. DR. REDDY’S LABORATORIES
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. AUROBINDO PHARMA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. GLAXOSMITHKLINE PLC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ASTRAZENECA PLC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

- Pfizer, Inc
- Novartis AG
- Baxter
- Teva Pharmaceutical Industries Ltd
- Hikma Pharmaceuticals plc
- Sanofi
- Dr. Reddy's Laboratories
- Aurobindo Pharma
- GlaxoSmithKline plc
- AstraZeneca plc.
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book